Xiaocun Sun1, Michael B Zemel. 1. Department of Nutrition, University of Tennessee, 1215 West Cumberland Avenue, #229, Knoxville, TN 37996-1900, USA.
Abstract
OBJECTIVE: We have previously shown 1alpha,25-dihydroxyvitamin D3 [1alpha,25-(OH)2D3] to inhibit mitochondrial uncoupling protein 2 (UCP2) expression in adipocytes and that in vivo suppression of calcitriol levels with calcium-rich diets increases UCP2 expression. Because UCP2 plays a significant role in the clearance of reactive oxygen species (ROS), we studied the effect of calcitriol on ROS production and ROS-induced adipocyte proliferation. RESEARCH METHODS AND PROCEDURES: ROS production in human and murine adipocytes was stimulated by high glucose (30 mM) or H2O2 (100 nM). RESULTS: Both approaches resulted in increased ROS production by 27% to 100% (p < 0.05) and increased cell proliferation by 15% to 39% (p < 0.03). These effects were augmented by the addition of mitochondrial uncoupling inhibitor guanosine 5'-diphosphate (GDP; 100 microM) or 1alpha,25-(OH)2D3 (10 nM) and attenuated by UCP2 overexpression, suggesting that inhibition of mitochondrial uncoupling suppresses clearance of ROS and increases adipocyte proliferation. The addition of alpha +/- tocopherol (1 microM) inhibited cell proliferation in adipocytes treated with either H2O2 or high glucose, indicating that ROS plays a major role in the regulation of cell proliferation in adipocytes. Moreover, stimulation of ROS with high glucose and H2O2 resulted in a 2- to 5-fold increase in adipocyte intracellular calcium ([Ca2+]i; p < 0.001), and calcium channel antagonism (nifedipine, 10 microM) suppressed ROS induced calcium influx and cell proliferation, indicating that [Ca2+]i may also regulate ROS production and exert a mitogenic effect in adipocytes. DISCUSSION: These data support a role of 1alpha,25-(OH)2D3, UCP2, and [Ca2+]i in the regulation of adipocyte ROS production.
OBJECTIVE: We have previously shown 1alpha,25-dihydroxyvitamin D3 [1alpha,25-(OH)2D3] to inhibit mitochondrial uncoupling protein 2 (UCP2) expression in adipocytes and that in vivo suppression of calcitriol levels with calcium-rich diets increases UCP2 expression. Because UCP2 plays a significant role in the clearance of reactive oxygen species (ROS), we studied the effect of calcitriol on ROS production and ROS-induced adipocyte proliferation. RESEARCH METHODS AND PROCEDURES: ROS production in human and murine adipocytes was stimulated by high glucose (30 mM) or H2O2 (100 nM). RESULTS: Both approaches resulted in increased ROS production by 27% to 100% (p < 0.05) and increased cell proliferation by 15% to 39% (p < 0.03). These effects were augmented by the addition of mitochondrial uncoupling inhibitor guanosine 5'-diphosphate (GDP; 100 microM) or 1alpha,25-(OH)2D3 (10 nM) and attenuated by UCP2 overexpression, suggesting that inhibition of mitochondrial uncoupling suppresses clearance of ROS and increases adipocyte proliferation. The addition of alpha +/- tocopherol (1 microM) inhibited cell proliferation in adipocytes treated with either H2O2 or high glucose, indicating that ROS plays a major role in the regulation of cell proliferation in adipocytes. Moreover, stimulation of ROS with high glucose and H2O2 resulted in a 2- to 5-fold increase in adipocyte intracellular calcium ([Ca2+]i; p < 0.001), and calcium channel antagonism (nifedipine, 10 microM) suppressed ROS induced calcium influx and cell proliferation, indicating that [Ca2+]i may also regulate ROS production and exert a mitogenic effect in adipocytes. DISCUSSION: These data support a role of 1alpha,25-(OH)2D3, UCP2, and [Ca2+]i in the regulation of adipocyte ROS production.
Authors: Tetsuya Tanikawa; Micha Fridman; Wenjiang Zhu; Brian Faulk; Isaac C Joseph; Daniel Kahne; Bridget K Wagner; Paul A Clemons Journal: J Am Chem Soc Date: 2009-04-15 Impact factor: 15.419
Authors: Daniela S Kempe; Teresa F Ackermann; Stephanie S Fischer; Saisudha Koka; Krishna M Boini; Hasan Mahmud; Michael Föller; Kevin P Rosenblatt; Makoto Kuro-O; Florian Lang Journal: Pflugers Arch Date: 2009-01-28 Impact factor: 3.657
Authors: Anna Liza B Valiña-Tóth; Zongshan Lai; Wonsuk Yoo; Abdul Abou-Samra; Crystal A Gadegbeku; John M Flack Journal: Clin Endocrinol (Oxf) Date: 2009-07-28 Impact factor: 3.478
Authors: Fábio S Lira; José C Rosa; Claudio A Cunha; Eliane B Ribeiro; Claudia Oller do Nascimento; Lila M Oyama; João F Mota Journal: Lipids Health Dis Date: 2011-02-27 Impact factor: 3.876